Synovus Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.06M Sell
7,904
-715
-8% -$86.8K 0.01% 505
2025
Q2
$1.07M Sell
8,619
-7,924
-48% -$1.01M 0.01% 487
2025
Q1
$2.1M Buy
16,543
+10,005
+153% +$1.54M 0.03% 347
2024
Q4
$941K Buy
+6,538
New +$938K 0.01% 490
2020
Q2
Sell
-1,900
Closed -$184K 2021
2020
Q1
$184K Buy
+1,900
New +$183K ﹤0.01% 786

Other funds holding RGEN

Synovus Financial's RGEN Position: Q3 2025 in Review

Synovus Financial reduced its Repligen (RGEN) stake by 8.3% in Q3 2025, selling an estimated $86.8K and leaving 7,904 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #505.

Synovus Financial first reported a position in RGEN in Q1 2020 and has held it in 5 quarters since. The position peaked at $2.1M in Q1 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Synovus Financial held 7,904 shares of Repligen worth $1.06M as of Q3 2025.
  • Synovus Financial sold 715 Repligen shares in Q3 2025, an estimated $86.8K.
  • Repligen made up 0.01% of Synovus Financial's portfolio in Q3 2025, its #505 holding.
  • Synovus Financial first reported a position in Repligen in Q1 2020 and has held it in 5 quarters since.
  • Synovus Financial's Repligen position peaked at $2.1M in Q1 2025.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.